Effect of the pediatric exclusivity provision on children's access to medicines

Title

Effect of the pediatric exclusivity provision on children's access to medicines

Creator

Grieve J; Tordoff J; Reith D; Norris P

Publisher

British Journal of Clinical Pharmacology

Date

2005

Subject

PedPal Lit; legislation & jurisprudence; supply & distribution United States%X AIMS: To determine the paediatric licensing status in the USA; Age Factors Australia Child Child; Australia and New Zealand of the 79 medicines granted paediatric exclusivity in the USA; by age grouping; Drug Licensure; Newborn Legislation; number of patients likely to be treated with each drug in a year; Preschool Drug Approval/legislation & jurisprudence Great Britain Humans Infant Infant; regarding: usefulness in patients with the condition; standards; statistics & numerical data New Zealand Pediatrics; statistics & numerical data Pharmaceutical Preparations; the Electronic Medicines Compendium (UK); UK

Description

2005

Rights

Article information provided for research and reference use only. PedPalASCNET does not hold any rights over the resource listed here. All rights are retained by the journal listed under publisher and/or the creator(s).

Type

Journal Article

Citation List Month

Backlog

Citation

Grieve J; Tordoff J; Reith D; Norris P, “Effect of the pediatric exclusivity provision on children's access to medicines,” Pediatric Palliative Care Library, accessed July 25, 2024, https://pedpalascnetlibrary.omeka.net/items/show/13497.